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  In this study， forty－five patients with malignant disease and as a control group seventy－one with
benign disease and four normal adult volunteers were selected．
  PHA was administered intradermally and the mean diameter was read at 24 hours．
  There was a close correlation between PHA and PPD skin test reactivity． Reactivity ta PHA
was not reduced even in the old patients of the control group， therefore PHA skin test reactivity was
considered not to be infiuenced with age．
  PHA skin reactivity was significantly reduced in patients with high－stage cancer as compared
to patients of the control group and those of low－stage cancer．
  We conclude that， as one of the indicators of ce11－mediated immunity， PHA skin tcs血g may
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Fig． 1． Correlation of PHA and PPD skin test．
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Fig． 2． PHA and PPD skin reactivity in
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Fig． （． PHA skin reactivity of male and
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Fig． 6． PHA skin reactivity of the patients with
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Fig． 7． PHA skin reactivity of the patient with
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Fig． 9． Changes of the PHA skin reactivity in
    the clinical course of two patients with
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